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Abstract Quercetin, which is the most abundant bioflavo-
noid compound, is mainly present in the glycoside form of
quercitrin. Although different studies indicated that quercitrin
is a potent antioxidant, the action of this compound is not well
understood. In this study, we investigated whether quercitrin
has apoptotic and antiproliferative effects in DLD-1 colon
cancer cell lines. Time and dose dependent antiproliferative
and apoptotic effects of quercitrin were subsequently deter-
mined by WST-1 cell proliferation assay, lactate dehy-
drogenase (LDH) cytotoxicity assay, detection of nucle-
osome enrichment factor, changes in caspase-3 activity,
loss of mitochondrial membrane potential (MMP) and
also the localization of phosphatidylserine (PS) in the
plasma membrane. There were significant increases in
caspase-3 activity, loss of MMP, and increases in the
apoptotic cell population in response to quercitrin in DLD-1
colon cancer cells in a time- and dose-dependent man-
ner. These results revealed that quercitrin has antiprolif-
erative and apoptotic effects on colon cancer cells.
Quercitrin activity supported with in vivo analyses
could be a biomarker candicate for early colorectal
carcinoma.
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Introduction
Colorectal cancer (CRC) is the third most common cancer
and the second highest cause of cancer-related death world-
wide with rapidly increasing rates due to many risk factors
including smoking, physical inactivity, obesity, red processed
meat and excessive alcohol consumption [1]. Progress in
diagnosis and treatment has had a positive effect on improv-
ing overall survival, with more patients being diagnosed in
the early stage of the disease, but the outcomes of patients
diagnosed with advanced stage disease remains quite poor
[2]. Understanding the molecular genesis of CRC is essential
for identification of novel molecular targets that might be
useful to define the prognosis of CRC patients [3]. Different
methods have been introduced to substantially reduce the
incidence and mortality of colon cancer cell lines. The search
for new compounds having anti-cancer effects in foods and
plant medicines gives rise to realistic and promising approach
for treatments [4]. A variety of compounds have undergone
clinical trials against colon cancer based on this strategy [5,
6]. Flavonoids are naturally occuring molecules that are
abundant in fruits, vegetables, nuts, seeds, and beverages
such as tea and wine. Studies have shown various biological
activities of flavonoids as inhibiting related cancer enzymes,
antioxidant, and immune response activities [7–11]. These
properties could explain the beneficial effects of these natural
molecules that have already been used in hypertension, in-
flammation, and cancer treatments [12]. Quercetin in the
glycoside form is the most abundant bioflavonoid compound
[13]. Quercitrin is a flavonoid with antinflammatory activity
in experimental colitis, associated with an antioxidative ac-
tion [14]. Recent studies demonstrated that quercitrin exhibits
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scavenger and anti-oxidant properties that increase the poten-
tial for quercitrin being an anti-carcinogenic [15]. Although
different studies indicated that quercitrin is a potent antioxi-
dant, the action of this compound is not well understood
[16–18]. Hence, we proposed to investigate whether
quercitrin has apoptotic and antiproliferative effects in
DLD-1 colon carcinoma cell lines.
Material & Methods
Cell Culture
The Dukes’ type C colorectal adenocarcinoma carcinoma cell
line DLD-1 was kindly provided by Dr.Yusuf Baran
(Department of Molecular Biology and Genetics, IYTE).
DLD-1 cell line was cultured in DMEM medium containing
1 % penicillin/streptomycin and 10 % fetal bovine serum at
37 °C in 5 % CO2.
Measurement of Cell Growth and Cytotoxicity
To detect the effect of quercitrin on cell viability after
treatment, a WST-1 cell proliferation assay was performed.
The WST-1 conversion assay (Roche, Germany) is based
on the mitochondrial function of intact cells that enables
them to metabolise the stable tetrazolium salt WST-1 (4-[3-
(4-iodophenyl)-2-(4-nitrophenyl)-2H-5-tetrazolio]-1,3-
benzene disulfonate) to a soluble violet formazan product.
Quanities of 1x104 cells/well were seeded into 96-well
plates containing 100 μl of the growth medium in the
absence or presence of increasing concentrations of
quercitrin and then incubated at 37 °C in 5 % CO2 for
24, 48 and 72 h. After the incubation period, cells were
treated with 10 μl of WST-1 for 4 h. Dye accumulation was
measured at 450 nm using a Multiscan ELISA reader
(Thermo Fisher Scientific, Germany). Viability was calcu-
lated by subtraction of the mean values without WST-1
from those with WST-1 substrate and was expressed as a
percentage of control. Data was confirmed by three other
independent experiments.
Cytotoxic effects of quercitrin in the dose and time de-
pendent manner were colorimetrically determined with a
“CytoTox 96R Non-Radioactive Cytotoxicity Assay” kit
from Promega (Madison, WI). Cell treatment to prepare
for cytotoxicity test was done as described for the WST-1
assay. Culture medium (10 μl) was then transferred to a 96-
well microtiter plate. The levels of lactate dehydrogenase
(LDH) were determined by adding 50 μl fresh substrate
mix, incubating in a dark at room temperature for 30 min,
then adding 50 μl stop solution, and measuring optical
density (OD) at 490 nm with a microplate reader (Bio-
Rad, Hercules, CA). The natural color of chemicals at
490 nm was corrected by subtracting the OD values of the
corresponding chemical×concentration medium that were
treated and measured in triplicates in the same manner as
with the cells. Data was confirmed by three other indepen-
dent experiments.
Detection of Apoptotic Nucleosomes and Necrotic DNA
Release
The Cell Death Detection Elisa plus (CDDE) kit is a photo-
metric enzyme-immunoassay to determine the quality and
quantity of DNA in terms of necrosis and cytoplasmic
his tone-associa ted DNA fragments (mono- and
oligonucleosomes) related to apoptosis in the supernatant of
treated cells (Roche, Germany). Application according to
manufacturer’s instruction provides concurrent detection of
apoptosis and necrosis in the same well. Colour development
of samples was determined by enrichment factor of the
amount of DNA fragments in cytoplasm or cell supernatant
indicating apoptosis or necrosis, respectively, and expressed
relative to untreated cells. In order to investigate possible
interference with the assay, particles were added to the cells
as two fold higher than the final concentration used in above
experiment (160 μg/cm2). Subsequently, the samples were
centrifuged (10 min, 200 g) conformance with the CDDE kit
protocol. The supernatant was then mixed 1:1 with lysate of
50 μm quercitrin treated cells for 48 and 72 h using the lysis
buffer included in the kit, and analysed according to manu-
facturer’s instructions.
Analysis of Phosphatidylserine Exposure and Cell
Permeability
During apoptotic cell death, phosphatidylserine (PS), which is
a phospholipid component of the inner-leaflet of cell mem-
brane, becomes available at the cell surface. This early marker
of apoptotic cell death can be detected by staining with the
green fluorescent dye Annexin V-FITC (BD Pharmingen,
Germany), a fluorochrome-conjugated Ca2+−dependent PS-
binding protein. In combination with the 7-AAD-DNA-stain-
ing, dye exclusion of vital cells permits a discrimination
between apoptotic and necrotic cells. Cells treated in 24-well
dishes were centrifuged (200 g, 5 min, 4 °C), washed with
HBSS−/− (GIBCO, Germany) and stained with 150 μl of
buffer (10 mM HEPES/NaOH pH 7.4, 150 mM NaCl,
5 mM KCl, 2 mM CaCl) containing 5 μl Annexin V-FITC
(1 mg/ml) and 1.5 μM 7-AAD at 37 °C. After 10 min, an
additional 500 μl of ice-cold buffer was added by the time the
cells were in the ice. After centrifugation (200 g, 5 min, 4 °C)
cells were suspended in 250 μl buffer and analysed immedi-
ately by flow cytometry using the green-collecting fluorescent
channels FL-1 for Annexin V-FITC and FL-3 for 7-AAD, as
described above. Quadrant separation in the fluorescent
334 Z.B. Cincin et al.
channels FL-1 (Annexin V-FITC) versus FL-3 (7-AAD) rep-
resents events of necrotic and apoptotic cells. 7-AAD positive
(Q1+Q2); apoptotic cells (Q3, Annexin V-FITC positive and
7-AAD negative) and viable cells (Q4, fluorescent negative)
were expressed as percentage of total cells.
Analysis of Caspase-3 Enzyme Activity
Changes in caspase-3 enzyme activity of the cells, which are
important signs of apoptosis, were examined using the
caspase-3 colorimetric assay kit (BioVision Research
Products,USA). This assay is based on spectrophotometric
detection of the chromophore p-nitroanilide (pNA) after
cleavage from the labeled substrate DEVD-pNA, which can
be recognized by caspase-3. In short, the cells (5×105 cells/
2 mL/well) that were induced to undergo apoptosis were
collected by centrifugation at 1,000 rpm for 10 min. The cells
were lysed by adding 50 μl of chilled cell lysis buffer and
incubated on ice for 10 min before centrifugation at 10,000 g
for 1 min. Supernatants were transferred to new Eppendorf
tubes, and 150 μl of cell lysis buffer was added to dilute the
samples. The reaction mixture was prepared in 96-well plates
by adding 50 μl of reaction buffer (containing 10 mM DTT),
50 μl of sample, and 5 μl of DEVD-pNA substrate and
incubated for 2 h at 37 °C in CO2 incubator. At the end of
this period, the plate was read under 405 nm wavelengths
using an Elisa reader (Thermo Electron Corporation
Multiskan Spectrum, Finland). The absorbance values are
normalized to protein concentrations determined using a
Bradford assay as described previously.
Determination of Changes in Mitochondrial Membrane
Potential
We also examined the loss of MMP, another important sign of
apoptosis, in response to quercitrin treatment for 48 h in DLD-
1 and MRC5 cells using the JC-1 Mitochondrial Membrane
Potential Detection Kit (Cayman Chemicals, USA). This kit
uses JC-1, a unique cationic dye, to signal the loss of the
MMP. JC-1 accumulates in the mitochondria which stain red
in nonapoptotic cells, while in apoptotic cells the MMP col-
lapses, and thus the JC-1 remains in the cytoplasm as a
monomer that stains green under fluorescent light. The cells
(5×105 cells/2 mL) were induced to undergo apoptosis and
collected by centrifugation at 1,000 rpm for 10 min.
Supernatants were removed, pellets were homogenized by
200 μl of medium, and 20 μl of JC-1 dye was added onto
the cells; then, the cells were incubated at 37 °C in 5 % CO2
for 30 min. Then, they were centrifuged at 400 g for 5 min,
supernatants were removed, and 200 μl of assay buffer was
added onto the pellets and vortexed. Then, this step was
repeated once more. Afterwards, all pellets were re-
suspended with 320 μl assay buffer and 100 μl from each of
them was added into the 96-well plate as triplicates. In healthy
cells, the aggregate in red form has absorption/emission max-
ima of 560/595 nm, whereas in apoptotic cells the monomeric
green form has absorption/emission maxima of 485/535 nm.
The plate was read at these wavelengths using a fluorescence
Elisa reader (Thermo Varioskan Spectrum, Finland). The
green/red (485/560) values were calculated to determine the
changes in MMP.
Statistical Analysis
Results are expressed as the mean standard error of the mean
(SEM). The data were analyzed using one-way ANOVA.
Results
Quercitrin Inhibited Proliferation of DLD-1 Colorectal
Carcinoma Cell Line in a Time- and Dose-Dependent Manner
To determine the antiproliferative effects of quercitrin on
DLD-1 colorectal carcinoma, the cells were incubated with
increasing concentrations of quercitrin for 24, 48, 72 h using a
WST-1 cell proliferation assay. The results of these assays
showed that there were time- and dose- dependent decreases
in cell proliferation when compared with controls only in the
colorectal carcinoma cell line (Fig. 1).
Quercitrin has Cytotoxic Effects on DLD-1 Colorectal
Carcinoma Cell Line in a Time- and Dose-Dependent Manner
To determine the cytotoxic effects of quercitrin on DLD-1
colorectal carcinoma, the cells were incubated with increasing
concentrations of quercitrin for 24, 48, 72 h using LDH assay.
The results of these assays showed that there were time- and
dose- dependent increases in cytotoxicity. (Fig. 2).
Fig 1 Effects of quercitrin on cell proliferation of DLD-1 cells. The
WST-1 assays were performed using triplicate samples in three indepen-
dent experiments. Statistical significance was determined using two-way
analysis of variance, p<0.05 (*) and p<0.01 (**) were considered
significant
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Quercitrin Increases Nucleosomal Enrichment Factor in Time
and Dose Dependent Manner
To determine the apoptotic effects of quercitrin on DLD-1
cells, these cells were incubated with increasing concentra-
tions of quercitrin for 48 and 72 h and changes in nucleosomal
enrichment factor (EF) were analyzed. There were subse-
quently 3.95 and 5.85 fold increases in EF in response to 48
and 72 h incubation with 50 μM quercitrin on DLD-1 cells, as
compared with untreated cells (Fig. 3).
Quercitrin Increases Caspase-3 Enzyme Activity in Time
and Dose Dependent Manner
To determine the apoptotic effects of quercitrin on DLD-1
cells, these cells were incubated with increasing concentra-
tions of quercitrin for 48 and 72 h. Changes in caspase-3
enzyme activities were analyzed. There was 1.5 fold increases
in caspase3 activity in response to 48 h incubation with 50μM
quercitrin on DLD-1 cells, as compared with untreated cells
(Fig. 4). Quercitrin induced apoptosis in a dose-dependent
manner could be related with caspase-3 activity.
Quercitrin Induces the Loss of Mitochondrial Membrane
Potential in a Time- and Dose- Dependent Manner
To assess the loss of MMP, DLD-1 cells, a JC-1 MMP assay
was performed after the cells were exposed to 50 μM
quercitrin for 48,72 h. The results of this assay revealed the
1.8 and 1.36 fold increases in loss of MMP in response to
50 μM quercitrin for 48 and 72 h DLD-1 cells respectively, as
compared with untreated cells (Fig. 5).
Quercitrin Causes the Modulation of the Cell Membrane
Resulting in the Translocation of PS from the Inner to Outer
Leaflet in a Time and Dose Dependent Manner
In order to confirm the results of caspase-3 activity and loss of
MMP, FITC AnnexinV/PI double staining was performed in
DLD-1 cells and The cells were exposed to 50 μM quercitrin
for 48 h was done. The results demonstrated that 50 μM
quercitrin increased the apoptotic cell death as compared with
the untreated control group (Fig. 6–7).
Discussion
Quercetin is the most ubiquitous flavonoid in nature, includ-
ing foods, which is usually present in a glycosylated form
such as quercitrin. It possesses various potentials as an anti-
oxidant, anti-inflammatory; however, the underlying mecha-
nisms leading to its anticancer effects is still unclear.
Comalada et al. analyzed the potency and efficacy of both
quercetin and quercitrin as anti-inflammatory compounds.
They examined the in vitro effects of quercitrin in the
Fig 2 Effects of quercitrin on cell cytotoxicity of DLD-cells. The LDH
cytotoxicity assays were performed using triplicate samples in three
independent experiments. Statistical significance was determined using
two-way analysis of variance, and p<0.05 (*) and p<0.01 (**) were
considered significant
Fig 3 Effects of quercitrin on apoptosis related nucleeosomal enrichment
factor of DLD-1 cells. The Cell Death detection plus ELISA were per-
formed using triplicate samples in at least two independent experiments.
Statistical significance was determined using two-way analysis of vari-
ance, and p<0.05 was considered significant
Fig 4 Effects of quercitrin on caspase3 activity in DLD-1 cells. Changes
in caspase-3 enzyme activity in response to increasing concentrations of
quercitrin in DLD-1 cells. The results are the means of two independent
experiments. p<0.05 was considered significant
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initiation and progression of the inflammation process in the
oxidative stage of colon carcinoma. Upregulated nitric oxide
synthase was inhibited in these rat colitis, in addition NF-ĸB
inactivation was detected [19].
The research on macrophage activity of quercetin and
quercitrin indicated that quercetin, instead of quercitrin, is
able to repress the proliferation and activation of macrophages
by inhibiting cytokine and nitric oxide formation, thus down
regulating the NFĸB pathway [20]. This study in rat collitis
confirmed the protective and therapeutic activity of quercitrin
[21]. Ding et al. examined the effects of quercitrin on neo-
plastic JB6 cells, the results demonstrated that the TPA-
induced neoplastic transformation is blocked in tumor cells.
They also showed that quercitrin stimulated the activation of
NF-E2-related factor (Nrf2), which is essential in the regula-
tion of cellular protective genes, and blocked damage in DNA
due to UVB [13].
Despite much inflammatory and protective cell researches,
there are limited studies about the anticancer effects of
quercitrin in the literature. Epidemiologic studies have
Fig 6 Effects of quercitrin (0 to 50microM) on apoptosis in DLD-1 cells.
FITC AnnexinV/PI double staining of DLD-1 cells treated with increas-
ing concentrations of quercitrin (a). Flow cytometric analysis of apoptosis
in DLD-1 cells (b). Early apoptotic cells labelled with Annexin-V but not
PI (shown in lower right quadrant) and apoptotic cells labelled with
Annexin-V and PI were found in the upper right quadrant in flow
cytometric graphics. The results are the means of two independent ex-
periments. p<0.05 was considered significant
Fig 5 Effects of quercitrin on membrane potential in DLD-1 cells. Loss
of mitochondrial membrane potential in response to increasing concen-
trations of quercitrin in DLD-1 cells. The results are the means of two
independent experiments. p<0.05 was considered significant
Fig 7 Effects of quercitrin (0 to 50microM) on apoptosis in DLD-1 cells.
FITC AnnexinV/PI double staining of DLD-1 cells treated with increas-
ing concentrations of quercitrin (a). Flow cytometric analysis of apoptosis
in DLD-1 cells (b). Early apoptotic cells labelled with Annexin-V but not
PI (shown in lower right quadrant) and apoptotic cells labelled with
Annexin-V and PI were found in the upper right quadrant in flow
cytometric graphics. The results are the means of two independent ex-
periments. p<0.05 was considered significant
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indicated that dietary flavonoids could have a role in oral
cancer. Brownning et al. examined whether quercitrin directly
affected cell proliferation in a human oral squamous carcino-
ma cell line. They found that quercitrin had no response to
antiproliferative activity as a result of minimal cellular uptake
and no hydrolysis of glycosides [22]. Xu and et al. studied the
molecular mechanisms of apoptosis on a prostate cancer cell
line PC3 induced by quercitrin and found that quercitrin
possessed little effect on inducing apoptosis [23].
In this study, we determined that quercitrin has antiprolif-
erative, cytotoxic and apoptotic affects as would be desirable
for a strategy for in cancer chemotherapy on colon carcinoma
cell lines in a dose and time dependent manner. Also, we
found that quercitrin exerts an apoptotic effect through the
loss of mitochondrial membrane potential. Nonfunctional mi-
tochondria played a role in the induction of apoptosis and
could be essential in the apoptotic pathway [24]. We hypoth-
esized that quercitrin affects colon cancer cell lines by im-
mune modulation.
In conclusion, taken together, all these data showed the
antiproliferative and apoptotic effects of quercitrin on colon
cancer cells. Based on the above results, quercitrin appears to
activate specific intracellular death-related pathways in DLD-
1 cells, leading to a loss of mitochondrial cell potential and
inducing apoptosis. Our findings suggest the possible use of
quercitrin against human colon cancer.
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